FOLD

Q: What is the price of Amicus Therapeutics (FOLD) today?

A cotação de Amicus Therapeutics (FOLD) hoje está em $ 0.00, com uma variação de The stock began the year trading around $ 14.24 and is currently priced at $ 0.00. negociando na casa dos $ 14.24 e hoje está em $ 0.00. Acompanhe o and track broader market trends directly on the platform.

Q: When does Amicus Therapeutics (FOLD) pay dividends?

Amicus Therapeutics (FOLD) did not pay dividends over the past year.

Q: Is Amicus Therapeutics (FOLD) a good investment?

Atualmente, Amicus Therapeutics (FOLD) está cotada a $ 0.00, com um P/L de -165.16, This represents a -6,490% premium compared to its historical average P/E. uma variação de 0 em sua cotação e distribuiu $ 0.00 em dividendos, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 0.00%.Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

Amicus Therapeutics Inc.

Price

$ -

return (12m)

0.00%

p/e

-165.16

p/bv

16.33

DIVIDEND YIELD

0.00%

FOLD price

FOLD

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment FOLD

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals FOLD

review the fundamentals of Amicus Therapeutics shares

P/E

-165.16

Sector: -67.28 Industry: -67.28

P/S (PSR)

7.06

Sector: -7.21 Industry: -7.21

P/BV

16.33

Sector: -1.96 Industry: -1.96

DIVIDEND YIELD (DY)

0.00%

Sector: -1.01% Industry: -1.01%

ROA

-2.85%

Sector: -280.42% Industry: -280.42%

ROE

-9.89%

Sector: -3,416.55% Industry: -3,416.55%

ROIC

7.70%

Sector: -2,574.67% Industry: -2,574.67%

NET MARGIN

-4.27%

Sector: -55.19% Industry: -55.19%

GROSS MARGIN

88.50%

Sector: 24.09% Industry: 24.09%

OPERATING MARGIN

5.44%

Sector: -54.09% Industry: -54.09%

EV/EBITDA

83.19

Sector: -1,328.82 Industry: -1,328.82

EV/EBIT

96.60

Sector: -435.04 Industry: -435.04

PRICE-TO-ASSETS

4.71

Sector: 1.01 Industry: 1.01

BVPS

0.89

Sector: -0.13 Industry: -0.13

EPS

-0.09

Sector: -3,516.58 Industry: -3,516.58

EQUITY-TO-ASSETS RATIO

0.29

Sector: -0.22 Industry: -0.22

LIABILITIES / ASSETS

0.71

Sector: 0.11 Industry: 0.11

CAGR REVENUE 5 YEARS

1,333.93%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

-35.90%

Sector: - Industry: -

Fundamentals FOLD

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JNJ	103.71	6.69	6.45%	2.31%	$ 542.92 B	21.76%
PFE	52.78	1.57	2.97%	6.90%	$ 141.82 B	18.60%
ABBV	535.81	-56.32	-10.51%	3.20%	$ 372.39 B	4.63%
NVO	26.47	6.33	23.91%	4.17%	$ 198.78 B	50.15%
AZN	91.32	5.94	6.50%	1.76%	$ 281.27 B	20.15%
GILD	79.63	6.87	8.63%	2.46%	$ 160.94 B	29.04%
BMY	43.39	5.78	13.32%	4.39%	$ 116.17 B	23.30%
ZTS	52.11	9.69	18.59%	2.74%	$ 31.32 B	26.57%
REGN	99.86	2.31	2.31%	0.51%	$ 72.62 B	20.17%
HALO	52.78	36.06	68.32%	0.00%	$ 7.92 B	39.83%
AMGN	96.87	19.17	19.79%	2.96%	$ 176.21 B	21.11%
MCK	55.17	-111.26	-201.68%	0.42%	$ 92.79 B	1.75%
HRMY	53.72	1.92	3.57%	0.00%	$ 1.75 B	15.08%
VRTX	107.61	5.73	5.33%	0.00%	$ 110.99 B	34.53%
CAH	114.64	-17.12	-14.93%	1.05%	$ 45.74 B	0.65%
ADMA	43.06	5.00	11.61%	0.00%	$ 1.95 B	39.59%
BIIB	88.77	1.52	1.71%	0.00%	$ 28.36 B	12.89%

Stock vs Indice Comparison Tool

If you had invested

years ago

2 years

5 years

10 years

ago, you would now have *

ago, you would now have:

*The value considers the reinvestment of dividends.

FOLD Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Amicus Therapeutics

Amicus Therapeutics Inc.

Average Investor10 user rating

4.0 (0 people)

United States

24 years

Founded: 2002

2007

Time since IPO - 19 years

483

Employees

Amicus Therapeutics Inc. (United States) is listed on the Nasdaq and has a market capitalization of $1,000.00 Trillions, with shareholders equity totaling $274.24 Millions.

The company employs approximately 483 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Amicus Therapeutics Inc. reported $185.21 Millions in revenue, generating net income of $1.69 Million.

Key financial metrics include a P/E ratio of -165.16, a price-to-book (P/B) ratio of 16.33, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker FOLD.

Market cap

$ 1,000.00 Trillions

Net worth

$ 274.24 Millions

$ 274,240,000.00

Assets

$ 949.87 Millions

$ 949,870,000.00

Total Shares Outstanding

309.00 Millions

309,000,000

Average Daily Trading Volume

$ 3.40 Millions

$ 3,402,295.14

Sector

Health Care

Industry

Biotechnology

FOLD

FOLD revenue and profits

Financial Results FOLD

DRAG THE FRAME TO SEE MORE DATA

FOLD cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BFRA - Biofrontera

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$ 760.57 5,44% (12M)

P/E

55.17

0.42%

ROE

-201.68%

P/BV

-111.26

CAH - Cardinal Health

$ 195.20 27,97% (12M)

P/E

114.64

1.05%

ROE

-14.93%

P/BV

-17.12

JNJ - Johnson & Johnson

$ 226.71 54,90% (12M)

P/E

103.71

2.31%

ROE

6.45%

P/BV

6.69

MRK - Merck & Co.

$ 111.38 51,73% (12M)

P/E

-64.94

2.98%

ROE

-9.23%

P/BV

5.99

AZN - AstraZeneca

$ 181.58 32,56% (12M)

P/E

91.32

1.76%

ROE

6.50%

P/BV

5.94

ABBV - AbbVie

$ 210.39 17,96% (12M)

P/E

535.81

3.20%

ROE

-10.51%

P/BV

-56.32

NVO - Novo Nordisk

$ 44.74 --27,13% (12M)

P/E

26.47

4.17%

ROE

23.91%

P/BV

6.33

BFRA - Biofrontera

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$ 760.57 5,44% (12 M)

P/L

55.17

0.42%

ROE

-201.68%

P/VP

-111.26

CAH - Cardinal Health

$ 195.20 27,97% (12 M)

P/L

114.64

1.05%

ROE

-14.93%

P/VP

-17.12

JNJ - Johnson & Johnson

$ 226.71 54,90% (12 M)

P/L

103.71

2.31%

ROE

6.45%

P/VP

6.69

MRK - Merck & Co.

$ 111.38 51,73% (12 M)

P/L

-64.94

2.98%

ROE

-9.23%

P/VP

5.99

AZN - AstraZeneca

$ 181.58 32,56% (12 M)

P/L

91.32

1.76%

ROE

6.50%

P/VP

5.94

ABBV - AbbVie

$ 210.39 17,96% (12 M)

P/L

535.81

3.20%

ROE

-10.51%

P/VP

-56.32

NVO - Novo Nordisk

$ 44.74 --27,13% (12 M)

P/L

26.47

4.17%

ROE

23.91%

P/VP

6.33

Frequently Asked Questions

What is the price of Amicus Therapeutics (FOLD) today?

A cotação de Amicus Therapeutics (FOLD) hoje está em $ 0.00, com uma variação de The stock began the year trading around $ 14.24 and is currently priced at $ 0.00. negociando na casa dos $ 14.24 e hoje está em $ 0.00. Acompanhe o and track broader market trends directly on the platform.

When does Amicus Therapeutics (FOLD) pay dividends?

Amicus Therapeutics (FOLD) did not pay dividends over the past year.

Is Amicus Therapeutics (FOLD) a good investment?

Atualmente, Amicus Therapeutics (FOLD) está cotada a $ 0.00, com um P/L de -165.16, This represents a -6,490% premium compared to its historical average P/E. uma variação de 0 em sua cotação e distribuiu $ 0.00 em dividendos, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 0.00%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Amicus Therapeutics (FOLD) stock?

You can buy Amicus Therapeutics (FOLD) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol FOLD and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of Amicus Therapeutics (FOLD) yield today?

Over the past month, Amicus Therapeutics (FOLD) has returned 0.00% — 0.00% over the past year, and 0.00% over the past five years, including price appreciation and dividends.

Nos últimos 12 meses, a empresa pagou um total de $ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Amicus Therapeutics (FOLD) hoje, o investimento total seria de $ 0.00, com base na cotação atual de $ 0.00.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: $ 0.00
Em 5 anos: $ 0.00
Em 10 anos: $ 0.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

FOLD

Amicus Therapeutics Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment FOLD

review the fundamentals of Amicus Therapeutics shares

P/E

P/S (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Amicus Therapeutics

Amicus Therapeutics Inc.

United States

24 years

2007

483

PROFIT X PRICE FOLD

Financial Results FOLD

FOLD cash flow

Asset, Revenue and Profit Growth - FOLD

FOLD balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

AZN - AstraZeneca

ABBV - AbbVie

NVO - Novo Nordisk

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

AZN - AstraZeneca

ABBV - AbbVie

NVO - Novo Nordisk

Frequently Asked Questions